Environ. Biosafety Res.
Volume 5, Number 4, October-December 2006Special issue
|Page(s)||233 - 235|
|Section||OECD Workshop on "Beyond the Blue Book. Framework for Risk/Safety Assessment of Transgenic Plants"|
|Published online||20 July 2007|
The OECD Blue Book on Recombinant DNA Safety Considerations: it's influence on ISBR and EFSA activities
Federal Biological Research Centre for Agriculture and Forestry, Institute
for Plant Virology, Microbiology and Biosafety, Braunschweig, Germany
Corresponding author: J.Schiemann@BBA.DE
Biosafety regulatory frameworks are intended to serve as mechanisms for ensuring the safe use of biotechnology products without imposing unacceptable risk to human health or the environment, or unintended constraints to technology transfer. The OECD Blue Book on "Recombinant DNA Safety Considerations", setting out principles and concepts for handling genetically modified organisms safely outside of contained laboratory conditions, was a milestone in the history of biotechnology. The "Recombinant DNA Safety Considerations" definitively became the major resource for the formulation of national regulatory frameworks and international regulations, including the Cartagena Protocol.
© ISBR, EDP Sciences, 2007
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.